References and Notes
1a
Ebel R. In Frontiers
in Marine Biotechnology
Proksch P.
Muller WEG.
Horizon
Bioscience;
England:
2006.
p.73-144
1b
Ramaswamy AV.
Flatt PM.
Edwards DJ.
Simmons TL.
Han B.
Gerwick WH. In Frontiers in Marine Biotechnology
Proksch P.
Muller WEG.
Horizon Bioscience;
England:
2006.
p.175-224
1c
Drugs
from the Sea
Fusetani N.
S.
Karger AG;
Basel:
2000.
1d
Fusetani N.
Matsunaga S.
Chem. Rev.
1993,
93:
1793
1e
Davidson BS.
Chem. Rev.
1993,
93:
1771
2a
Proksch P.
Edrada R.
Lin WH. In Frontiers
in Marine Biotechnology
Proksch P.
Muller WEG.
Horizon
Bioscience;
England:
2006.
p.1-20
2b
Newman DJ.
Gragg GM.
J.
Nat. Prod.
2004,
67:
1216
2c
Proksch P.
Edrada RA.
Ebel R.
Appl.
Microbiol. Biotechnol.
2002,
59:
125
2d
Frenz JL.
Kohl AC.
Kerr RG.
Expert Opin. Ther. Pat.
2004,
14:
17
2e
Wipf P.
Chem. Rev.
1995,
95:
2115
3
Helms GL.
Moore RE.
Niemczura WP.
Patterson
GML.
J.
Org. Chem.
1988,
53:
1298
4a
Liang S.
Xu Z.
Ye T.
Chem. Commun.
2010,
46: in press;
DOI: 10.1039/b921000h
4b
Li S.
Liang S.
Tan WF.
Xu ZS.
Ye T.
Tetrahedron
2009,
65:
2695
4c
Ren Q.
Dai L.
Zhang H.
Tan WF.
Xu ZS.
Ye T.
Synlett
2008,
2379
4d
Li S.
Liang S.
Xu ZS.
Ye T.
Synlett
2008,
569
4e
Chen Z.
Ye T.
New J. Chem.
2006,
30:
518
4f
Pang HW.
Xu ZS.
Chen ZY.
Ye T.
Lett. Org.
Chem.
2005,
2:
699
4g
Peng YG.
Pang HW.
Xu ZS.
Ye T.
Lett.
Org. Chem.
2005,
2:
703
4h
Xu ZS.
Ye T.
Tetrahedron: Asymmetry
2005,
16:
1905
4i
Chen HL.
Xu ZS.
Ye T.
Tetrahedron
2005,
61:
11132
4j
Chen ZY.
Ye T.
Synlett
2005,
2781
4k
Xu ZS.
Chen Z.
Ye T.
Tetrahedron:
Asymmetry
2004,
15:
355
4l
Peng YG.
Pang HW.
Ye T.
Org. Lett.
2004,
6:
3781
4m
Chen ZY.
Deng JGYeT.
ARKIVOC
2003,
(vii):
268
4n
Xu ZS.
Peng YG.
Ye T.
Org.
Lett.
2003,
5:
2821
For the synthesis of racemic and
enantiomerically enriched 4-hydroxy-3-methylproline, please see:
5a
Anderson JC.
Flaherty A.
J. Chem.
Soc., Perkin Trans. 1
2001,
267
5b
Anderson JC.
O’Loughlina JMA.
Tornos JA.
Org.
Biomol. Chem.
2005,
3:
2741
6a
Brown HC.
Bhat KS.
J.
Am. Chem. Soc.
1986,
108:
293
6b
Brown HC.
Bhat KS.
Randad RS.
J. Org. Chem.
1989,
54:
1570
7a
Harding KE.
Burks SR.
J. Org. Chem.
1981,
46:
3920
7b
Harding KE.
Burks SR.
J.
Org. Chem.
1984,
49:
40
7c
Harding KE.
Marman TH.
J.
Org. Chem.
1984,
49:
2838
7d
Kinsman R.
Lathbury D.
Vernon P.
Gallagher T.
J. Chem. Soc., Chem. Commun.
1987,
243
7e
Tokuda M.
Yamada Y.
Suginome H.
Chem.
Lett.
1988,
17:
1289
7f
Takahata H.
Takehara H.
Ohkubo N.
Momose T.
Tetrahedron: Asymmetry
1990,
1:
561
7g
Takahata H.
Bandoh H.
Momose T.
Tetrahedron: Asymmetry
1991,
2:
351
7h
Singh S.
Chikkanna D.
Singh OV.
Han H.
Synlett
2003,
1279
7i
Khalaf JK.
Datta A.
J. Org. Chem.
2004,
69:
387
7j
Chikkanna D.
Han H.
Synlett
2004,
2311
8a
Katsuki T.
Sharpless KB.
J.
Am. Chem. Soc.
1980,
102:
5974
8b
Gao Y.
Hanson RM.
Klunder JM.
Ko SY.
Masamune H.
Sharpless KB.
J.
Am. Chem. Soc.
1987,
109:
5765
9a
Markad SD.
Karanjule NS.
Sharma T.
Sabharwal SG.
Puranik VG.
Dhavale DD.
Org. Biomol. Chem.
2006,
4:
2549
9b
Benedetti F.
Berti F.
Dinon F.
Nardin G.
Norbedo S.
Org. Lett.
2004,
6:
1017
9c
Saotome C.
Kanie Y.
Kanie O.
Wong C.-H.
Bioorg. Med. Chem.
2000,
8:
2249
9d
Beier C.
Schaumann E.
Synthesis
1997,
1296
9e
Gleave DM.
Brickner SJ.
J.
Org. Chem.
1996,
61:
6470
9f
Kim NS.
Choi JR.
Cha JK.
J.
Org. Chem.
1993,
58:
7096
9g
Carpenter NM.
Fleet GWJ.
Di Bello IC.
Winchester B.
Fellows LE.
Nash RJ.
Tetrahedron Lett.
1989,
30:
7261
10
De Luca L.
Giacomelli G.
Porcheddu A.
Org.
Lett.
2001,
3:
3041
11
Yu W.
Mei Y.
Kang Y.
Hua Z.
Jin Z.
Org. Lett.
2004,
6:
3217
12
Procedure for
the Synthesis of 4 via Epoxide Opening
Epoxide 5 (0.65 g, 1.6 mmol) was dissolved in MeOH
(10 mL). After a catalytic amount of Pd/C (10%)
was added, the reaction was exposed to an atmosphere of H2 at
ambient temperature. The reaction was monitored by TLC. After all starting
material was consumed (ca. 2 h), the reaction mixture was stirred
for an additional 1 h and then filtered through a pad of Celite.
The filter cake was washed with MeOH (10 mL). The combined filtrate
and washings were concentrated in vacuo to leave the corresponding
amine as an oil, which was dissolved in THF-H2O
(20 mL, 1:1) at 0 ˚C and treated with NaHCO3 (0.25
g, 3.0 mmol) and CbzCl (0.29 mL, 2.0 mmol). The reaction mixture
was stirred at r.t. for 3 h and then concentrated in vacuo. The
residue was extracted with EtOAc (3 × 20
mL). The combined organic phases were washed with brine (30 mL),
dried over anhydrous Na2SO4, and concentrated
in vacuo. The residue was purified by flash chromatography on silica
gel, eluting with EtOAc-hexane (2:3) to give desired product 4 (0.49 g, 75%); [a]D
²5 -6.6
(c 0.70, CHCl3). ¹H
NMR (500 MHz, CDCl3): δ = 7.40-7.29
(m, 5 H), 5.17 (s, 2 H), 4.17 (d, J = 3.3
Hz, 1 H), 4.11 (d, J = 9.0
Hz, 1 H), 3.73 (dd, J = 4.2, 7.1
Hz, 1 H), 3.61-3.58 (m, 4 H), 3.34 (dd, J = 4.1,
11.6 Hz, 1 H), 3.09-3.07 (m, 1 H), 2.18 (dd, J = 6.9, 11.5
Hz, 1 H), 1.12 (d, J = 6.9
Hz, 3 H), 0.88 (s, 9 H), 0.07 (s, 3 H), 0.04 (s, 3 H). ¹³C
NMR (125 MHz, CDCl3): δ = 157.7, 136.3, 128.5 (128.5),
128.2, 128.0 (127.9), 73.4, 72.2, 67.6, 65.7, 62.9, 54.5, 41.4,
25.8 (25.7), 18.0, 13.0, -4.9, -5.0 ppm. ESI-HRMS: m/z calcd for C21H36NO5Si+ [M + H]+:
410.2351; found: 410.2375.
13
Bal BS.
Childers WE.
Pinnick HW.
Tetrahedron
1981,
37:
2091
14
Sarraf ST.
Leighton JL.
Org. Lett.
2000,
2:
403
15
Procedure for
the Synthesis of 11 via Amidomercuration-Oxidation
To
a stirred solution of compound 8 (0.88
g, 2.40 mmol) in MeCN (20 mL), Hg(OAc)2 (2.26 g, 7.20
mmol) was added. The reaction mixture was refluxed for 2 h and then
cooled to r.t. EtOAc (10 mL) and brine (10 mL) were added, and the mixture
was stirred at r.t. for a further 1.5 h and filtered to remove the
precipitated inorganic byproduct. The filtrate was separated and
the aqueous layer was extracted with EtOAc (3 × 50
mL). The combined organic phases were dried over anhydrous Na2SO4 and
concentrated in vacuo to give 7 as a colorless
foam. In a second reaction vessel, oxygen (O2) was bubbled
into a well-stirred solution of NaBH4 (0.09 g, 2.4 mmol)
in DMF (25 mL) at r.t. One hour later, the above intermediate in
DMF (25 mL) was slowly added over 2 h, while maintaining the flow
of oxygen. Upon completion of addition, the reaction mixture was
stirred for additional 2 h and then filtered through a pad of Celite, eluting
thoroughly with EtOAc (200 mL). The filtrate was concentrated in
vacuo, and the residue was purified by flash chromatography (EtOAc-hexane, 3:1)
to afford the diastereoisomers 11α (0.23
g, 26%) and 11β (0.22
g, 24%).
Analytical Data for
11α
[α]D
²5 +28.6
(c 0.54, CHCl3). ¹H
NMR (500 MHz, CDCl3); δ = 7.37-7.27
(m, 5 H), 5.22-5.09 (m, 2 H), 4.24-4.02 (m, 2 H),
3.94-3.79 (m, 2 H), 3.72-3.66 (m, 1 H), 3.60-3.55
(m, 1 H), 3.52-3.42 (m, 1 H), 2.46-2.33 (m, 1
H), 1.07 (1.05) (d, J = 7.4
Hz, 3 H), 0.92 (0.91) (s, 9 H), 0.14 (0.09) (s, 6 H) ppm. ¹³C
NMR (125 MHz, CDCl3): δ = 156.1 (154.9),
136.7, 128.5, 128.0, 127.9, 73.4 (72.8), 67.1, 62.8 (61.9), 61.5 (59.8),
56.1 (55.4), 41.4 (40.7), 25.7, 18.0, 9.9 (9.7), -4.8,
-5.1
ppm. ESI-HRMS: m/z calcd for
C20H34NO4Si+ [M + H]+:
380.2252; found: 380.2268.
Analytical
Data for 11β
[α]D
²5 -2.0
(c 0.16, CHCl3). ¹H
NMR (500 MHz, CDCl3):
δ = 7.38-7.33
(m, 5 H), 5.35-5.10 (m, 2 H), 4.85 (br, 1 H) 4.05 (br,
1 H), 3.82-3.80 (m, 1 H), 3.70-3.66 (m, 1 H),
3.62-3.58 (m, 2 H), 3.38 (dd, J = 3.0,
13.4 Hz, 1 H), 1.84-1.77 (m, 1 H), 1.06 (d, J = 6.7 Hz,
3 H), 0.87 (s, 9 H), 0.06 (s, 3 H), 0.04 (s, 3 H) ppm. ¹³C
NMR (125 MHz, CDCl3): δ = 157.4, 136.4,
128.5, 128.0, 127.8, 72.3, 67.3, 65.9, 65.6, 55.6, 41.4, 25.7, 18.0,
11.9, -4.8, -5.0 ppm. ESI-HRMS: m/z calcd
for C20H34NO4Si+ [M + H]+:
380.2252; found: 380.2264.
16 See Supporting Information.